Actrapid: Opinion on medicine for use outside EU

insulin human

Opinion on medicine for use outside the European Union
Positive opinion


Actrapid is a medicine for treating diabetes. It contains human insulin as its active substance.

This overview is for Actrapid intended for use outside the EU. An identical product with the same name is authorised in the European Union. For Actrapid intended for use outside EU there is an additional storage option requiring less refrigeration.

Opinion details

Product details
Name of medicinal product
Agency opinion number
Opinion status
Positive opinion
Active substance
insulin human
International non-proprietary name (INN) or common name
insulin human
Therapeutic area (MeSH)
Diabetes Mellitus
Anatomical therapeutic chemical (ATC) code
Publication details
Opinion holder

Novo Nordisk A/S
Novo Alle 1 2880


Date of opinion

Product information

22/04/2022 Actrapid H-W-005779


Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.

Pharmacotherapeutic group

Drugs used in diabetes

Therapeutic indication

Actrapid is indicated for treatment of diabetes mellitus.

Assessment history

How useful was this page?

Add your rating